Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O W Brawley

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Urology|May 1, 1994
Chemoprevention of prostate cancerO W Brawley, I M Thompson
Epidemiologic Reviews|October 9, 2001
Potential agents for prostate cancer chemopreventionO W Brawley, S T Barnes
Journal of the National Cancer Institute|November 24, 1999
Race and outcomes: is this the end of the beginning for minority health research?O W Brawley, H P Freeman
Military Medicine|February 5, 2000
Association of Helicobacter pylori infection with gastric cancerG A Alexander, O W Brawley
Seminars in Urologic Oncology|December 19, 1998
Prostate cancer research and the National Cancer InstituteO W Brawley, N Figueroa-Valles
Epidemiology (Cambridge, Mass.)|March 1, 1997
Prostate cancer incidence and mortality rates among white and black menR M Merrill, O W Brawley
Annals of the New York Academy of Sciences|January 25, 2002
The future of prostate cancer preventionO W Brawley, S Barnes, H Parnes
Seminars in Urologic Oncology|December 19, 1998
The epidemiology of prostate cancer part I: descriptive epidemiologyO W Brawley, K Knopf, R Merrill
Seminars in Urologic Oncology|December 19, 1998
The epidemiology of prostate cancer part II: the risk factorsO W Brawley, K Knopf, I Thompson
Oncology (Williston Park, N.Y.)|April 1, 1996
Clinical trials referral resource. Cancer chemoprevention and control trialsO W Brawley, B D Cheson, P H Phillips
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Urology|May 1, 1994
Chemoprevention of prostate cancerO W Brawley, I M Thompson
Epidemiologic Reviews|October 9, 2001
Potential agents for prostate cancer chemopreventionO W Brawley, S T Barnes
Journal of the National Cancer Institute|November 24, 1999
Race and outcomes: is this the end of the beginning for minority health research?O W Brawley, H P Freeman
Military Medicine|February 5, 2000
Association of Helicobacter pylori infection with gastric cancerG A Alexander, O W Brawley
Seminars in Urologic Oncology|December 19, 1998
Prostate cancer research and the National Cancer InstituteO W Brawley, N Figueroa-Valles
Epidemiology (Cambridge, Mass.)|March 1, 1997
Prostate cancer incidence and mortality rates among white and black menR M Merrill, O W Brawley
Annals of the New York Academy of Sciences|January 25, 2002
The future of prostate cancer preventionO W Brawley, S Barnes, H Parnes
Seminars in Urologic Oncology|December 19, 1998
The epidemiology of prostate cancer part I: descriptive epidemiologyO W Brawley, K Knopf, R Merrill
Seminars in Urologic Oncology|December 19, 1998
The epidemiology of prostate cancer part II: the risk factorsO W Brawley, K Knopf, I Thompson
Oncology (Williston Park, N.Y.)|April 1, 1996
Clinical trials referral resource. Cancer chemoprevention and control trialsO W Brawley, B D Cheson, P H Phillips
Pageof 4